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Abstract
Organic anion transporting polypeptide 1a1 (Oatp1a1) is predominantly expressed in liver and is able to transport bile acids
(BAs) in vitro. Male Oatp1a1-null mice have increased concentrations of taurodeoxycholic acid (TDCA), a secondary BA
generated by intestinal bacteria, in both serum and livers. Therefore, in the present study, BA concentrations and intestinal
bacteria in wild-type (WT) and Oatp1a1-null mice were quantified to investigate whether the increase of secondary BAs in
Oatp1a1-null mice is due to alterations in intestinal bacteria. The data demonstrate that Oatp1a1-null mice : (1) have similar
bile flow and BA concentrations in bile as WT mice; (2) have a markedly different BA composition in the intestinal contents,
with a decrease in conjugated BAs and an increase in unconjugated BAs; (3) have BAs in the feces that are more
deconjugated, desulfated, 7-dehydroxylated, 3-epimerized, and oxidized, but less 7-epimerized; (4) have 10-fold more
bacteria in the small intestine, and 2-fold more bacteria in the large intestine which is majorly due to a 200% increase in
Bacteroides and a 30% reduction in Firmicutes; and (5) have a different urinary excretion of bacteria-related metabolites than
WT mice. In conclusion, the present study for the first time established that lack of a liver transporter (Oatp1a1) markedly
alters the intestinal environment in mice, namely the bacteria composition.
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Introduction
Bile acids (BAs) are synthesized from cholesterol, conjugated
with taurine or glycine in liver, secreted into bile, and then
delivered to the intestine. The majority of BAs are absorbed from
the intestine and return to the liver, which together is known as the
enterohepatic circulation of BAs [1,2]. In rodents, primary BAs,
which are synthesized in liver include cholic acid (CA),
chenodeoxycholic acid (CDCA), a-muricholic acid (aMCA), and
bMCA. Secondary BAs are formed from primary BAs by bacterial
enzymes in the intestine. The major secondary BAs in rodents are
deoxycholic acid (DCA), lithocholic acid (LCA), and murideoxy-
cholic acid (MDCA), which are the 7-dehydroxylation products of
CA, CDCA, and a/bMCA, respectively. The bacterial metabo-
lism of BAs as well as the structures and abbreviations of various
BAs are shown as Fig. 1.
The intestinal microbiota in both humans and mice consist
mainly of Bacteroidetes and Firmicutes phyla [3,4]. More than 95% of
the Firmicutes are members of the Clostridia class. Non-culture based
techniques that rely on 16 S rRNA gene sequences are
increasingly being used for the identification and classification of
bacterial species [4,5].
Bacterial bile salt hydrolases (BSHs) catalyze BA deconjuga-
tion, and hydroxysteroid dehydrogenases (HSDHs) catalyze BA
oxidation and epimerization [6]. Only a few species of intestinal
bacteria have been examined to determine their ability to
metabolize BAs. For example, Clostridium (C.) absonum (expresses
both 7a-a n d7 b-HSDHs, and is able to epimerize CDCA to
ursodeoxycholic acid (UDCA) [7,8]. C. perfringens expresses both
BSH [9] and HSDHs [10]. C. scindens expresses both 3a-a n d7 a-
HSDHs, and also has high BA 7a-dehydroxylation activity [11].
BSHs are also expressed in Lactobacillus (La.) acidophilus, La.
reuteri, and Bacteroides (Ba.) vulgatus [12,13,14]. Ba. distasonis has BA
7b-dehydroxylation activity [15].
Organic anion transporting polypeptides (human: OATPs;
rodents: Oatps) mediate the transport of a variety of structurally
diverse endogenous compounds (such as prostaglandins, thyroid
hormones, conjugated steroids, and BAs) and xenobiotics (such as
anticancer drugs, antibiotics, cardiac glycosides, and some
peptides) [16]. In mice, Oatp1a1, 1a4, and 1b2 are predominantly
expressed in liver [17]. Oatp1a1 has been shown to transport BAs,
such as taurocholic acid (TCA) in vitro [18]. Thus, Oatp1a1 is
thought to transport BAs in vivo from blood into liver. In a previous
study, Oatp1a1-null mice were found to have increased secondary
BAs (DCA and TDCA) in serum, a finding that could not be
attributed to decreased hepatic uptake, as might be expected in
this model [19]. These Oatp1a1-null mice also showed increased
urinary excretion of isethionic acid, a taurine metabolite produced
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the intestinal microbiome. Accordingly, we hypothesized that the
increase of DCA and TDCA in serum of Oatp1a1-null mice is due
to an increase in intestinal bacteria, and therefore the purpose of
the present study is to investigate the in vivo role of Oatp1a1 in BA
metabolism and intestinal bacteria composition.
Results
BA Concentrations in Feces
A previous study demonstrated that secondary BAs including
DCA and TDCA, which are produced by intestinal bacteria, were
increased in the serum of Oatp1a1-null mice [19]. To investigate
whether the increased secondary BAs in serum of Oatp1a1-null
mice is due to alterations in intestinal BA metabolism, the BA
concentrations in the feces of Oatp1a1-null mice were quantified.
Fig. 2a illustrates the concentrations of conjugated primary BAs in
feces of mice. Lack of Oatp1a1 markedly decreased TCA (80%),
TCDCA (60%), TaMCA (80%), and TbMCA (90%). Fig. 2b
illustrates the concentrations of unconjugated primary BAs in feces
of mice. Lack of Oatp1a1 decreased CA about 65%, but had no
effect on CDCA. Lack of Oatp1a1 increased aMCA about 95%,
but decreased bMCA about 30%. BA sulfates can be desulfated by
bacterial enzymes in the intestine [21], and in Oatp1a1-null mice,
sulfated BAs were markedly decreased. These included TCA-7S
and TCDCA-7S, which were virtually non-detectable in the
Oatp1a1-null mice, as well as 40% decrease in CA-7S and 80%
decrease in CDCA-7S (Fig. 2c). Taken together, lack of Oatp1a1
appeared to alter both the conjugation and sulfation of BAs in the
intestine of mice.
Bacteria-mediated 7-dehydroxylation is a major modification of
BAs in the intestine. DCA and LCA are 7-dehydroxylation
products of CA and CDCA, respectively. In mice, MDCA is
thought to be produced by 7-dehydroxylation of bMCA, and
HDCA is produced by further epimerization of MDCA [22]. Lack
of Oatp1a1 increased GDCA (420%), TMDCA (170%), and
THDCA (1700%), DCA (1300%), LCA (1900%), and HDCA
(1700%) (Fig. 2d and 2e). UDCA is produced by 7-epimerization
of CDCA by bacterial enzymes in the intestine [23], and in the
absence of Oatp1a1, both TUDCA and UDCA were decreased 75
and 60%, respectively (Fig. 2d and 2e). Therefore, lack of
functional Oatp1a1 increased 7-dehydroxylation, but decreased 7-
epimerization of BAs in the intestine of mice.
IsoDCA and isoLCA are produced by the 3a/b-epimerization
of DCA and LCA, respectively. The concentrations of isoDCA
(1300%) and isoLCA (1900%) were increased markedly in feces of
Oatp1a1-null mice (Fig. 2f). The concentrations of oxo-BAs, such
as dehydroLCA (4300%), 6-oxoLCA (700%), 7-oxoLCA (70%),
and 12-oxoLCA (1300%) were also increased markedly in the
feces of Oatp1a1-null mice (Fig. 2f). Therefore, lack of Oatp1a1
increased 3-epimerization and oxidation of BAs in the intestine of
mice.
Figure 1. Bacteria-mediated BA metabolism. (a) Deconjugation, dehydroxylation, oxidation, and epimerization of cholic acid (CA) in the
intestine of mice. Black dotted arrows represent for deconjugation, black solid arrows represent for 7-dehydroxylation, grey dotted arrows represent
for oxidation, grey solid arrows represent for epimerization; (b) Deconjugation, dehydroxylation, oxidation, and epimerization of chenodeoxycholic
acid (CDCA) and muricholic acid (MCA) in the intestine of mice. Black dotted arrows represent for deconjugation, black solid arrows represent for 7-
dehydroxylation, grey dotted arrows represent for oxidation, grey solid arrows represent for epimerization; (c) Structures and abbreviations of various
BAs. TCA and GCA stand for taurocholic acid and glycocholic acid, respectively.
doi:10.1371/journal.pone.0034522.g001
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To investigate whether BA alterations in feces are due to altered
hepatic BA metabolism and/or biliary BA excretion, the
concentrations of individual BAs in livers and bile of WT and
Oatp1a1-null mice were quantified. Lack of Oatp1a1 had little
effect on the concentrations of unconjugated BAs in liver (Fig. 3a).
Lack of Oatp1a1 also had little effect on most conjugated BAs in
liver, except that it increased the concentration of TDCA about
200% (Fig. 3b). In addition, lack of Oatp1a1 had no effects on bile
flow (data not shown) or the concentrations of BAs in bile of mice
(Fig. 3c and 3d). Taken together, lack of Oatp1a1 increased
TDCA concentrations in liver, but had little effect on the
composition of BAs in bile.
BA Composition in the Intestinal Contents
Because the concentrations of BAs in bile are similar between
WT and Oatp1a1-null mice, alterations in the fecal BA
composition are most likely caused by changes in BA metabolism
in the intestinal contents. As shown in Fig. 4a, the major
unconjugated BAs in the small intestinal contents of WT mice
were vMCA, bMCA, and CA, whereas in Oatp1a1-null mice,
unconjugated BAs were markedly increased including CA (330%),
MDCA (1150%), UDCA (170%), HDCA (220%), CDCA (130%),
and DCA (1000%). The conjugated BAs were the predominant
BAs in the small intestinal contents of WT mice (Fig. 4b). The two
major conjugated BAs in WT mice were TMCA and TCA. In
contrast in Oatp1a1-null mice, TMCA (60%) and TUDCA (81%)
were decreased markedly.
The major BAs in the large intestinal contents of WT mice were
unconjugated BAs (Fig. 4). Lack of Oatp1a1 decreased bMCA
(40%) and UDCA (69%), but increased CDCA (210%), MDCA
(320%), HDCA (150%), DCA (310%), and LCA (320%) (Fig. 4d).
Lack of Oatp1a1 decreased TMCA (70%), TUDCA (70%), and
TCDCA (50%), but increased TDCA about 280% in the large
intestinal contents (Fig. 4d).
Bacteria in Intestinal Contents
To investigate whether altered BA metabolism in the intestinal
contents of Oatp1a1-null mice is due to alterations in intestinal
bacteria, we developed a 16 S rDNA-based assay to quantify
Figure 2. Concentrations of primary and secondary BAs in the feces of WT and Oatp1a1-null mice. Feces were collected from WT and
Oatp1a1-null mice for 24 hr and dried under vacuum. The concentrations of primary BAs (a, b, and c) and secondary BAs (d, e, and f) in the feces of
male WT and Oatp1a1-null mice (n=5/group) were analyzed using ultra performance liquid chromatography-tandem mass spectrometry (UPLC-MS/
MS) and normalized by fecal dry weight. All data are expressed as mean 6 S.E. of five mice in each group. *, statistically significant difference between
WT and Oatp1a1-null mice (p,0.05).
doi:10.1371/journal.pone.0034522.g002
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illustrates the relative amount of Clostridia in both small and large
intestine of WT and Oatp1a1-null mice. In the small intestine of
Oatp1a1-null mice, there was an increase in the following
bacteria: C. absonum (85%), C. perfringens (350%), C. scindens
(100%), C. methylpentosum (110%), and C. sp. ASF502(ii) (220%).
In contrast, the large intestine of Oatp1a1-null mice showed a
decrease in almost all Clostridia, including C. absonum (30%), C.
perfringens (30%), C. sindens (50%), C. fusiformis (30%), C. celerecrescens
(30%), C. sp. ASF502 (i, ii and iii) (45%), C. clostridiiformes (65%), C.
polysaccharolyticum (50%), and C. celerecrescence (40%).
As shown in Fig. 5b, the small intestine of Oatp1a1-null mice
had a 50–100 fold increase in almost all the Bacteroides, including
Ba. acidifaciens, Ba. forsythus (i and ii), Ba. vulgatus, Ba. sp. ASF519,
and Ba. distasonis (i, ii, iii, iv, and v). In addition, the large intestine
of Oatp1a1-null mice also had an increase in Ba. acidofaciens
(105%), Ba. forsythus (ii and ii) (250%), Ba. sp. ASF519 (540%), Ba.
distasonis (i, ii, and iv) (300–400%), and Ba. distasonis (iii and v) (78–
88 fold).
The small intestine of Oatp1a1-null mice had an increase in
several Lactobacilli (Fig. 5c), such as La. acidophilus (190%), La. reuteri
(200%), and La. sp. ASF519 (90%). In contrast, the large intestine
of Oatp1a1-null mice had a decrease in La. acidophilus (13%) and
La. murinus (40%).
As shown in Fig. 5d, the small intestine of Oatp1a1-null mice
underwent a 100–800% increase in Lactococcus lactis, Klebsiella
granulomatis, Streptococcus gordnii, Eubacterium desmolans, Ralstonia sp.,
Eubacterium limosum, Acetibibrio cellulosolvens, and Ruminococcus gnavus,
as well as 2000–10,000% increase in Prevotella sp. (i, and ii),
Porphyromonas sp.(i), Desulfovibrio sp., and Porphyromonas sp.(ii). In
contrast, the large intestine of Oatp1a1-null mice underwent a
decrease in Streptococcus gordnii (25%), Ruminococcus schinkii (40%),
Ruminococcus gnavus (35%), but increased Prevotella sp. (i, and ii)
(200%), Porphyromonas sp. (i) (170%), Porphyromonas sp. (ii) (9000%),
and Helicobactor sp. (600%).
Fgf15-Fgfr4 Pathway
Fxr plays a key role in the regulation of BA homeostasis. Fig. 6
illustrates the mRNA expression of Fxr, Shp, and Fgf15 in ilea as
well as Fgfr4 in livers of WT and Oatp1a1-null mice. Lack of
Oatp1a1 had little effect on ileal Fxr mRNA expression, whereas
Oatp1a1-null mice had lower ileal Shp mRNA than did WT mice.
In addition, Oatp1a1-null mice tended to have lower mRNA
expression of Fgf15 in ilea and Fgfr4 in livers than WT mice,
although this difference was not statistically significant.
Urinary Metabolomic Analysis
The gut microbiota interact extensively with the host through
metabolic exchange and co-metabolism of substrates. To investi-
gate the effects of the altered intestinal bacteria on host
metabolism, we collected the urine of WT and Oatp1a1-null
mice and performed metabolomic analysis using UPLC-TOF-MS.
Consistent with a previous study [20], urinary metabonomic
analysis in the present study also revealed a distinct separation
between WT and Oatp1a1-null mice (Fig. S1). Chemical
structural elucidations were performed based on accurate mass
measurement and MS/MS fragmentations. By comparison of the
retention time in the same MS/MS chromatograph window
between authentic standards and urine samples, we identified that
Oatp1a1-null mice had higher hippuric acid, but lower indole-3-
carboxylic acid-glucuronide (indole-3-carboxylic acid-G) in urine
than WT mice (Fig. 7). In addition, Oatp1a1-null mice had lower
glucuronides of daidzein and O-desmethylangolensin in urine than
WT mice (Fig. S2 and S3).
Figure 3. BA concentrations in livers (a and b) and bile (c and d) of mice. BA concentrations in livers and bile of male WT and Oatp1a1-null
mice (n=5/group) were analyzed using ultra performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS). All data are expressed
as mean 6 S.E. for five mice in each group. *, statistically significant difference between WT and Oatp1a1-null mice (p,0.05).
doi:10.1371/journal.pone.0034522.g003
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The role of OATP/Oatps in transporting a wide range of
structurally unrelated xenobiotics, including numerous drugs and
toxins, has drawn the attention of scientists regarding the drug-
drug or food-drug interactions that might occur at the transporter
level. However, due to the lack of specific inhibitors, the
physiological roles of the OATP/Oatp family of transporters still
remain unclear. In the present study, we utilized Oatp1a1-null
mice and illustrated that this transporter contributes to the
regulation of intestinal bacteria population.
The human intestine provides residence to 1610
13 bacteria,
which is ten-fold higher than the total number of cells in the
human body (1610
12), and contains a genome with 100-fold more
genes than that of humans [24,25]. These bacteria represent an
integral component of the human body, and a dynamic
contributor to systems biology. Numerous toxicants have been
shown to alter the urinary excretion of bacteria-related metabolites
[26]. However, there are limited data regarding the altered
intestinal bacteria in the genetically modified animals. In the
present study, Oatp1a1-null mice were shown to have a markedly
different profile of intestinal bacteria, which resulted in the altered
urinary excretion of bacteria-formed metabolites such as hippuric
acid and indole-3-carboxylic acid [27,28]. The novelty of the
present finding that loss of Oatp1a1 function leads to alterations in
intestinal bacteria is indicative of the complex and relatively
unexplored relationship between intestinal bacteria and other
organs such as liver.
Intestinal bacteria play a critical role in the metabolism and
circulation of BAs. Table S1 and S2 summarized the concentra-
tions or composition of BAs in tissues or contents of WT and
Oatp1a1-null mice. Oatp1a1-null mice had similar bile flow (data
not shown) and BA concentrations in the bile as WT mice (Fig. 3c
and 3d), suggesting that lack of Oatp1a1 does not alter the
amounts of BAs entering the small intestine. However, due to the
increase in small intestinal bacteria, conjugated BAs (TMCA and
TUDCA) decreased, whereas unconjugated BAs (CA, MDCA,
HDCA, UDCA, CDCA, and DCA) increased in the small
intestinal contents of Oatp1a1-null mice (Fig. 4a and 4b).
Consistently, Oatp1a1-null mice also had a markedly different
BA profile in the feces, with a decrease in conjugated primary BAs
(taurine-, glycine-, and sulfate-conjugated BAs) and an increase in
secondary BAs that are produced by 7-dehydroxylation, oxidation,
and epimerization (Fig. 2). Unlike other secondary BAs, both
TUDCA and UDCA were decreased in the feces of Oatp1a1-null
mice (Fig. 2). This may be due to the decrease in C. absonum, which
expresses both 7a- and 7b-HSDHs, and thus is able to epimerize
CDCA to UDCA [7,8]. Despite the marked changes in BA
composition, Oatp1a1-null mice had a similar fecal excretion of
total BAs as WT mice (data not shown), consistent with the similar
biliary excretion of BAs into the intestine.
Emerging evidence suggests a strong interaction between gut
microbiota and human health [29]. Overgrowth of intestinal
bacteria is a well-known phenomenon in gastroenterology and
pathology [30,31]. However, the causative mechanisms are not
known. The present study provides evidence that the overgrowth
Figure 4. BA composition in the small (a and b) and large (c and d) intestinal contents of mice. BA concentrations in the intestinal
contents of male WT and Oatp1a1-null mice (n=5/group) were analyzed using ultra performance liquid chromatography-tandem mass spectrometry
(UPLC-MS/MS). All data are expressed as mean 6 S.E. for five mice in each group. *, statistically significant difference between WT and Oatp1a1-null
mice (p,0.05).
doi:10.1371/journal.pone.0034522.g004
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and bile excreting machineries. For example, overgrowth of
Klebsiella frequently gives rise to severe diseases such as
septicemia, pneumonia, and soft tissue infection [32]. The present
study demonstrates a potential role of liver transporters and bile
acids in the homeostasis of Klebsiella. Alterations in intestinal
bacteria can also be a contributing factor to the pathophysiology of
obesity. The intestinal microbiota in both humans and mice
consist mainly of Bacteroidetes and Firmicutes phyla [3,4]. The
relative proportion of Bacteroidetes is decreased in obese people, and
increased when these obese people change to a low-calorie diet
[33]. Similarly, genetically obese (ob/ob) mice have a 50%
reduction in the abundance of Bacteroidetes, in the cecal contents
[33]. Interestingly, the mRNA and protein expression of Oatp1a1
in livers of obese (ob/ob) mice were diminished to ,5% and
,15%, respectively, of that in WT mice [34]. In addition, hepatic
Oatp1a1 is also suppressed by a high-fat diet in rats [35]. In
contrast to ob/ob mice, the present study shows that Oatp1a1-null
mice have a 200% increase of Bacteroidetes, and a 30% reduction of
Firmicutes in the large intestine. Thus, there is evidence to suggest
that Oatp1a1 expression is altered in the face of metabolic disease
such as obesity, and that the function of this transporter is critical
for the homeostasis of intestinal bacteria populations.
FXR has been shown to play an important role in preventing
bacterial overgrowth and maintaining the integrity of the intestinal
epithelium. For example, administration of GW4064, a FXR
agonist, blocks bacterial overgrowth and translocation in ilea and
ceca of BDL mice [36]. In ileum, the majority of intestinal BAs are
absorbed in their conjugated forms via BA transporters, namely
the apical sodium dependent bile acid transporter (Asbt) and the
organic solute transporter a/b (Osta/b). Lack of Oatp1a1
decreases the concentrations of conjugated BAs in ilea, and thus
may decrease the influx of BAs into ileal enterocytes, resulting in
decreased FXR activation. Although lack of Oatp1a1 had little
effect on ileal FXR mRNA expression, it significantly decreased
the mRNA expression of ileal SHP, a target gene of FXR
(Figure 6). In addition, both ileal Fgf15 and hepatic Fgfr4 mRNA
expression tend to decrease in Oatp1a1-null mice. This indicates
that Oatp1a1-null mice may have a decreased BA-mediated FXR
activation in the ilea, which may contribute to the overgrowth of
intestinal bacteria. However, it remains unclear how lack of
Oatp1a1 alters the intestinal bacteria. It is also possible that lack of
Oatp1a1 alters the disposition of some endogenous substrates,
other than BAs, which are important in maintaining normal
intestinal functions.
In summary, the present study provides a new perspective on
the in vivo functions of OATPs/Oatps, which are extensively
engaged in drug absorption, distribution, and elimination. The
alteration of OATP expression and activities can affect the plasma
concentration of drugs, thereby significantly influencing drug
toxicities, therapeutic efficacies, and drug-drug interactions [37].
The present study suggests that inhibition of Oatp1a1 in mice may
result in an overgrowth of intestinal bacteria and thereby an
increase of secondary BAs in serum and intestinal contents. The
present study also suggests a potential role of OATPs/Oatps in
nutrition and obesity. For example, loss of Oatp1a1 function alters
urinary excretion of daidzein and its bacteria-mediated metabolite
O-desmethylangolensin, which have been shown to have beneficial
effects on obesity, hypertension, cholesterol, and glucose levels in
animals and humans [38]. Therefore, the effects of OATPs/Oatps
on intestinal bacteria, BA metabolism, and host metabolomics
should be considered when studying drug-induced liver injuries
and drug-drug interactions.
Materials and Methods
Chemicals and Reagents
BA standards were purchased from Steraloids, Inc. (Newport,
Rhode Island) and Sigma-Aldrich (St Louis, MO). Turocholate-7-
sulfate was kindly provided by Dr Alan F Hofmann (University of
California-San Diego).
Animals and Breeding
All animal studies were approved by the Institutional Animal
Care and Use Committee at the University of Kansas Medical
Center. Eight-week-old adult male C57BL/6 mice were purchased
from Charles River Laboratories Inc. (Wilmington, MA).
Oatp1a1-null mice were bred to homozygosity on the C57BL/6
background as described previously [20]. All mice were housed in
an American Animal Associations Laboratory Animal Care
(AAALAC) accredited facility with a 12:12 hr light:dark cycle
and provided chow (Teklad Rodent Diet #8604, Harlan Teklad,
Madison, WI) and water ad libitum.
Sample Collection
Age-matched male WT and Oatp1a1-null mice (n=6/group)
were anesthetized i.p. using ketamine (100 mg/kg)/midazolam
(5 mg/kg) and the common bile duct was cannulated with a 30-
gauge needle attached to PE-10 tubing. Bile was collected from the
cannula for 2 hrs at 15-min intervals. Another set of mice (n=5/
group) were anesthetized, blood was collected by orbital bleeding,
and serum was obtained by centrifuging blood at 6,000 g for
15 min. Livers with gallbladders removed were harvested from the
same animals, washed, frozen in liquid nitrogen, and stored at
280uC. Small intestine, cecum, and large intestine were divided,
cut open, and vortexed in 3 ml of saline to collect contents,
respectively. The three small intestine segments, namely duode-
Fremont, CA). All data are expressed as mean 6 S.E. of five mice in each group. *, statistically significant difference between WT and Oatp1a1-null
mice (p,0.05).
doi:10.1371/journal.pone.0034522.g005
Figure 6. mRNA of Fxr, Shp, and Fgf15 in ilea as well as Fgfr4 in
livers of mice. Total RNA from ilea and livers of male WT and Oatp1a1-
null mice (n=5/group) was analyzed using multiplex suspension array.
The mRNA of each gene was normalized to GAPDH. All data are
expressed as mean 6 S.E. of five mice in each group. *, statistically
significant difference between WT and Oatp1a1-null mice (p,0.05).
doi:10.1371/journal.pone.0034522.g006
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were stored separately at 280uC.
BA Extraction from Intestinal Contents
To extract BAs from mouse intestinal contents, preliminary
experiments were performed to optimize BA extraction. Briefly,
intestinal contents were mixed with 100 ml of internal standards
(
2H4-GCDCA and
2H4-CDCA) and centrifuged at 12,000 g for
10 min to collect the supernatant. The pellet was extracted with
3 ml of methanol twice. The mixture was centrifuged at 12,000 g
for 20 min to collect the supernatants. The three supernatants
were pooled, evaporated under vacuum, and reconstituted in 1 ml
of 50% methanol.
BA Extraction from Feces
Age-matched male WT and Oatp1a1-null mice (n=9/group)
were acclimated to metabolic cages (housed individually), and
feces were collected on ice over a 24-hr period. Mouse feces were
dried under vacuum, and ground to a powder. Fifty mg of feces
were mixed with BA internal standards and 3 ml of methanol was
added. After shaking for 1 hr at room temperature, the mixture
was centrifuged at 20,000 g for 10 min to collect the supernatant.
The pellet was extracted with another 2 ml of methanol. The two
supernatants were pooled, evaporated under vacuum, and
reconstituted in 100 ml of 50% methanol.
BA Quantification
BA concentrations were quantified by ultra performance liquid
chromatography-tandem mass spectrometry (UPLC-MS/MS)
[39]. BA stock solutions were diluted with 50% methanol and
spiked with internal standards (
2H4-GCDCA and
2H4-CDCA) to
construct standard curves between 5 and 20,000 ng/ml. All
standard curves were constructed using a 1/concentration
2
weighted quadratic regression, and the correlation coefficient (r
2)
for all BAs was above 0.99. The limit of detection (signal/noise
ratio=3) for the various BAs was in the range of 5–10 ng/ml,
which equals 0.01–0.02 nmol/ml.
Bacterial DNA Extraction
Age-matched male WT and Oatp1a1-null mice (n=6/group)
were anesthetized, and intestinal contents were collected in
phosphate buffered saline containing 10 mM dithiothreitol
(DTT), and centrifuged at 20,000 g for 30 min at 4uC. Total
genomic bacterial DNA was extracted from the pellet using
Figure 7. Oatp1a1-null mice had higher hippuric acid, but lower indole-3-carboxylic acid-glucuronide in urine than WT mice.
Structural elucidations were performed based on accurate mass measurement and MS/MS fragmentations of hippuric acid (a) and indole-3-carboxylic
acid-glucuronide (b) in urine of WT and Oatp1a1-null mice. By comparison of the retention time in the same MS/MS chromatograph window between
authentic standards and urine samples, hippuric acid (c) and indole-3-carboxylic acid-G (d) were confirmed. The authentic standard indole-3-
carboxylic acid-glucuronide (indole-3-carboxylic acid-G) was enzymatically synthesized from indole-3-carboxylic acid.
doi:10.1371/journal.pone.0034522.g007
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instructions. The integrity, concentration, and quality of the total
DNA were assessed by agarose gel electrophoresis, and determined
by absorption at A260, and A260 to A280 ratio, respectively. DNA
solutions were stored at 220uC until further analysis.
Bacterial Quantification
The bacteria evaluatedin the presentstudywerechosenbased on
a previous report on the major intestinal microflora in mice [4].
Because the majority of the bacteria residing in the intestine were
unculturable, the bacterial seuqneces are defined as the closest
known relative in the phylogenic tree [4]. A strategy based on
quantification of the 16 S rDNA gene by branched DNA (bDNA)
assay was utilized to compare the composition of intestinal
microbiota of WT and Oatp1a1-null mice. The 16 S rDNA gene
assay was performed using Quantigene 2.0 Reagent System
(Panomics/Affymetrix, Fremont, CA) according to the manufac-
turer’s protocol. Briefly, the oligonucleotide probes targeted against
the 16 S rDNA gene sequences of various bacteria were
manufactured by Panomics/Affymetrix (Fremont, CA). Accession
numbers for the corresponding bacteria are given in Table 1. The
catalog # of each bDNA probe can be reached at www.panomics.
com. Our dose-response study determined that the optimal DNA
input is 20 ng (Fig. S4). Thus, total bacterial DNA (1 ng/ml, 20 ml)
was added to each well containing 80 ml of lysis buffer containing
blocking reagent and each probe set. Sample DNA was allowed to
hybridize to each probe set overnight at 55uC. Subsequently, the
plate was washed with washing buffer three times. Samples were
hybridized with the amplification reagent (100 ml/well) in the
amplifier/label probe buffer for 1 h at 55uC. The plate was washed
3 times with wash buffer. Label probe diluted in amplifier/label
probe buffer was added to each well (100 ml/well), and the alkaline
phosphatase-conjugated label probe was allowed to hybridize to the
bDNA-DNA complex for 1 h at 50uC. The plate was washed with
wash buffer three times. The enzyme reaction was triggered by the
additionofsubstratesolution(100 ml/well)and incubatedfor5 min.
The resulting luminescence was quantified using a luminometer set
at an integration time of 0.2 sec.
Total RNA Isolation
Total RNA was isolated using RNA-Bee reagent (Tel-Test Inc.,
Friendswood, TX) according to the manufacturer’s protocol. Total
RNA concentrations were quantified spectrophotometrically at
260 nm. Integrity of RNA samples was determined by formalde-
hyde-agarose gel electrophoresis with visualization by ethidium
bromide fluorescence under ultraviolet light.
Multiplex Suspension Array
The mRNA expression was quantified by mutiplex suspension
array (Panomics/Affymetrix, Fremont, CA). Individual gene
accession numbers can be accessed at www.panomics.com (sets
#21021 and #21151). Samples were analyzed using a Bio-Plex
200 System Array reader with Luminex 100 xMAP technology,
and the data were acquired using Bio-Plex Data Manager version
5.0 (Bio-Rad, Hercules, CA). Assays were performed according to
the manufacture’s protocol. mRNA data were normalized to
Gapdh mRNA and presented as relative light units (RLUs).
Metabolomic analysis of urine
Urinary samples were prepared by mixing 40 ml of urine with
160 ml of 50% acetonitrile and centrifuged at 20,000 g for 10 min.
A 100 mm62.1 mm UPLC BEH C18 column (Waters) was used
Table 1. Gene accession numbers of the 16 s rRNA gene
assessed in this study.
Bacterial substrains NCBI Accession #.
1 Acetibibrio cellulosolvens AJ418058
2 Bacillus mycoides AJ308388
3 Bacteroid distasonis (i) AJ400243
4 Bacteroid distasonis (ii) AJ400242
5 Bacteroid distasonis (iii) AJ400241
6 Bacteroid distasonis (iv) AJ400234
7 Bacteroid forsythus (i) AJ400249
8 Bacteroid forsythus (ii) AJ400236
9 Bacteroid vulgatus AJ400246
10 Bacteroides distasonis (v) AJ400254
11 Bacteroids acidofaciens AJ400252
12 Bacteroids sp. ASF519 AJ400245
13 Bifidobacterium animalis AB027536
14 Candidatus xiphinematobactor AJ400275
15 Clostridium absonum X77842
16 Clostridium celerecrescence (i) AJ400265
17 Clostridium celerecrescens (ii) AJ400256
18 Clostridium clostridiiformes AJ400247
19 Clostridium fusiformis AJ400260
20 Clostridium methylpentosum AJ400237
21 Clostridium perfringens FJ384389
22 Clostridium polysaccharolyticum AJ400272
23 Clostridium scindens AY878326
24 Clostridium sp AJ400251
25 Clostridium sp. ASF502 (i) AJ400255
26 Clostridium sp. ASF502 (ii) AJ308396
27 Clostridium sp. ASF502 (iii) AJ400261
28 Desulfovibrio sp. AJ308394
29 Eubacterium desmolans AJ400270
30 Eubacterium limosum AB298910
31 Helicobactor sp. AJ308389
32 Klebsiella granulomatis EU333881
33 Lactobacillus acidophilus (i) AJ400238
34 Lactobacillus murinus AJ308393
35 Lactobacillus reuteri AJ308392
36 Lactobacillus salivarius FJ378897
37 Lactobacillus sp. ASF519 AJ308390
38 Lactobaciluus acidophillus (ii) AJ300391
39 Lactococcus lactis FJ378886
40 Porphyromonas sp. (i) AJ400264
41 Porphyromonas sp. (ii) AJ400235
42 Prevotella sp. (i) AJ400267
43 Prevotella sp. (ii) AJ400266
44 Ralstonia sp. AJ308395
45 Ruminococcus gnavus AJ308386
46 Ruminococcus schinkii AJ400250
47 SFB AJ308387
48 Streptococcus gordnii EU156758
Role of Oatp1a1 on Mouse Intestinal Bacteria
PLoS ONE | www.plosone.org 9 April 2012 | Volume 7 | Issue 4 | e34522for metabolite separation. The flow rate of the mobile phase was
0.3 ml/min with a gradient ranging from 2 to 98% aqueous
acetonitrile containing 0.1% formic acid in a 10-min run. TOF-
MS was operated in both positive and negative modes with
electrospray ionization. The source temperature and desolvation
temperature were set at 120 and 350uC, respectively. Nitrogen was
applied as the cone gas (10 L/h) and desolvation gas (700 L/h),
and argon as the collision gas. TOF-MS was calibrated with
[Glu1]-fibrinopeptide and monitored by the intermittent injection
of lock mass leucine enkephalin in real time. The capillary voltage
and the cone voltage were set at 3.5 kV and 35 V in the positive
ion mode. Screening and identification of major metabolites were
performed by using MarkerLynx software (Waters) based on
accurate mass measurement (mass errors less than 10 ppm). Mass
chromatograms and mass spectra were acquired by MassLynx
software in centroid format from 50 to 1000 m/z. Centroid and
integrated mass chromatographic data were processed by
MarkerLynx software to generate a multivariate data matrix.
Principal component analysis (PCA) and orthogonal projection to
latent structures-discriminant analysis (OPLS-DA) were conducted
on Pareto-scaled data. The corresponding data matrices were then
exported into SIMCA-P+ (version 12; Umetrics, Kinnelon, NJ) for
multivariate data analysis.
Statistical Analysis
Data are expressed as mean 6 S.E. (n=5–6). Differences
between two mean values were tested for statistical significance
(p,0.05) by the two-tailed Student’s t-test.
Supporting Information
Figure S1 Metabonomic analysis of WT and Oatp1a1-
null mouse urine. Urine of two-month old male WT and
Oatp1a1-null mice (n=9) were collected for analysis. (a)
Separation of WT and Oatp1a1-null mouse urine in a PCA score
plot with operation of the TOF-MS in the positive mode. The t [1]
and t [2] values represent the score of each sample in principal
component 1 and 2, respectively. (b) Loading S-plot generated by
OPLS-DA analysis of metabonome in urine of Oatp1a1-null mice
with the operation of the TOF-MS in the positive mode. The X-
axis is a measure of the relative abundance of ions and the Y-axis is
a measure of the correlation of each ion to the model. These
loading plots represent the relationship between variables (ions) in
relation to the first and second components present in the PCA
score plot. (c) Separation of WT and Oatp1a1-null mouse urine in
a PCA score plot with operation of TOF-MS in the negative
mode. (d) Loading S-plot generated by OPLS-DA analysis of
metabonome in urine of Oatp1a1-null mice with the operation of
TOF-MS in the negative mode.
(TIF)
Figure S2 Oatp1a1-null mice had lower glucuronides of
daidzein and O-desmethylangolensin in urine than WT
mice. Structural elucidations were performed based on accurate
mass measurement (mass errors less than 10 ppm) and MS/MS
fragmentations of glucuronidated-daidzein (a) and glucuronidated-
O-desmethylangolensin (b) in urine of WT and Oatp1a1-null mice.
(TIF)
Figure S3 Confirmation of glucuronidated daidzein and
daidzein in urine of WT and Oatp1a1-null mice. The
authentic standard daidzein glucuronides were enzymatically
synthesized from daidzein. The enzymatic reaction of daidzein
resulted in three glucuronidated-daidzeins, suggesting that daid-
zein can be glucuronidated at different positions. There is one
peak with the same retention time as one of glucuronidated-
daidzeins in the urine samples (a). In addition, there are four peaks
with the same molecular weight as daidzein in the urine samples,
one of which was confirmed as daidzein by the authentic standard
(b).
(TIF)
Figure S4 The effect of DNA input on luminescence of
selected bacterial bDNA probes during bacterial quan-
tification. Total bacterial DNA was added to each well
containing 80 ml of lysis buffer containing blocking reagent and
each probe set. Sample DNA was allowed to hybridize to each
probe set overnight at 55uC. Subsequently, the plate was washed
with washing buffer three times. Samples were hybridized with the
amplification reagent (100 ml/well) in the amplifier/label probe
buffer for 1 h at 55uC. The plate was washed 3 times with wash
buffer. Label probe diluted in amplifier/label probe buffer was
added to each well (100 ml/well), and the alkaline phosphatase-
conjugated label probe was allowed to hybridize to the bDNA-
DNA complex for 1 h at 50uC. The plate was washed with wash
buffer three times. The enzyme reaction was triggered by the
addition of substrate solution (100 ml/well) and incubated for
5 min. The resulting luminescence was quantified using a
luminometer set at an integration time of 0.2 sec.
(TIF)
Table S1 Concentrations or composition of individual BAs in
tissues or contents of WT and Oatp1a1-null mice. The
concentrations of BAs in male WT and Oatp1a1-null mice
(n=5/group) were analyzed using ultra performance liquid
chromatography-tandem mass spectrometry (UPLC-MS/MS).
All data are expressed as mean 6 S.E. of five mice in each group.
*, statistically significant difference between WT and Oatp1a1-null
mice (p,0.05).
(DOC)
Table S2 Calculated secondary BAs and unconjugated BAs in
tissues or contents of WT and Oatp1a1-null mice. All data are
expressed as mean 6 S.E. of five mice in each group. *, statistically
significant difference between WT and Oatp1a1-null mice
(p,0.05).
(DOC)
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